Fatigue in Inflammatory Joint Diseases

被引:5
|
作者
Chmielewski, Grzegorz [1 ]
Majewski, Michal S. [2 ]
Kuna, Jakub [1 ]
Mikiewicz, Mateusz [3 ]
Krajewska-Wlodarczyk, Magdalena [1 ]
机构
[1] Univ Warmia & Mazury, Sch Med, Dept Rheumatol, Coll Medicum, PL-10900 Olsztyn, Poland
[2] Univ Warmia & Mazury, Fac Med, Dept Pharmacol & Toxicol, PL-10082 Olsztyn, Poland
[3] Univ Warmia & Mazury, Fac Vet Med, Dept Pathol Anat, PL-10719 Olsztyn, Poland
关键词
fatigue; inflammation; cytokines; inflammatory joint diseases; INTERLEUKIN-6 RECEPTOR INHIBITION; RHEUMATOLOGY BIOLOGICS REGISTER; ANKYLOSING-SPONDYLITIS; PSORIATIC-ARTHRITIS; SICKNESS BEHAVIOR; BRITISH SOCIETY; SERUM-LEVELS; DOPAMINE; THERAPY; ALPHA;
D O I
10.3390/ijms241512040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatigue is a prevalent symptom in various rheumatic diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is characterised as a subjective, enduring feeling of generalised tiredness or exhaustion, impacting the patient's life quality and exacerbating disability. The fatigue nature is multifaceted, encompassing physiological, psychological, and social factors, and although the exact cause of inflammatory joint diseases is not fully understood, several factors are believed to contribute to its development. Despite high prevalence and importance, the symptom is often underestimated in clinical practice. Chronic inflammation, commonly associated with rheumatic diseases, has been proposed as a potential contributor to fatigue development. While current treatments effectively target inflammation and reduce disease activity, fatigue remains a persistent problem. Clinical evaluation of rheumatic diseases primarily relies on objective criteria, whereas fatigue, being a subjective symptom, is solely experienced and reported by the patient. Managing fatigue in inflammatory joint diseases involves a multifaceted approach. Identifying and comprehensively assessing the subjective components of fatigue in individual patients is crucial for effectively managing this symptom in everyday clinical practice.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] PERIPHERAL NEUROPATHY IN INFLAMMATORY JOINT DISEASES
    Yehudina, Y.
    Syniachenko, O.
    Bevzenko, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1775 - 1775
  • [22] MRI in inflammatory joint diseases - An introduction
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 18 - 18
  • [23] Nitric oxide and inflammatory joint diseases
    Stichtenoth, DO
    Frölich, JC
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (03): : 246 - 257
  • [24] JOINT MANIFESTATIONS IN INFLAMMATORY BONE DISEASES
    ZINN, WM
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1974, 33 : 125 - 134
  • [25] Chronobiology and Chronotherapy in Inflammatory Joint Diseases
    Ursini, Francesco
    De Giorgi, Alfredo
    D'Onghia, Martina
    De Giorgio, Roberto
    Fabbian, Fabio
    Manfredini, Roberto
    PHARMACEUTICS, 2021, 13 (11)
  • [26] Work in inflammatory and degenerative joint diseases
    Gobelet, C.
    Luthi, F.
    Al-Khodairy, A. T.
    Chamberlain, M. A.
    DISABILITY AND REHABILITATION, 2007, 29 (17) : 1331 - 1339
  • [27] Radionuclide therapy of inflammatory joint diseases
    Fischer, M
    Mödder, G
    NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (09) : 829 - 831
  • [28] The temporomandibular joint and inflammatory rheumatic diseases
    Marotte, H.
    REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE, 2016, 117 (04) : 223 - 227
  • [29] Hydrogen Sulfide and Inflammatory Joint Diseases
    Burguera, Elena F.
    Meijide-Failde, Rosa
    Blanco, Francisco J.
    CURRENT DRUG TARGETS, 2017, 18 (14) : 1641 - 1652
  • [30] THERAPY OF INFLAMMATORY AND DEGENERATIVE JOINT DISEASES
    CHLUD, K
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1980, 130 : 12 - 27